Cite

    Soubhye, J. et al. (n.d.). Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome. Journal of pharmacy and pharmacology. pp. 1122-1132. [Online].